124 related articles for article (PubMed ID: 38017580)
1. Characterization of APOE Christchurch carriers in 455,306 UK Biobank participants.
He KY; Khramtsova EA; Cabrera-Socorro A; Zhang Y; Li S; Sarver BAJ; Smets B; Li QS; De Muynck L; Parrado AR; Lovestone S; Black MH
Mol Neurodegener; 2023 Nov; 18(1):92. PubMed ID: 38017580
[No Abstract] [Full Text] [Related]
2. Investigating the synergistic effects of hormone replacement therapy, apolipoprotein E and age on brain health in the UK Biobank.
Ambikairajah A; Khondoker M; Morris E; de Lange AG; Saleh RNM; Minihane AM; Hornberger M
Hum Brain Mapp; 2024 Feb; 45(2):e26612. PubMed ID: 38339898
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer disease genetic risk factor APOE e4 and cognitive abilities in 111,739 UK Biobank participants.
Lyall DM; Ward J; Ritchie SJ; Davies G; Cullen B; Celis C; Bailey ME; Anderson J; Evans J; Mckay DF; Mcintosh AM; Sattar N; Smith DJ; Deary IJ; Pell JP
Age Ageing; 2016 Jul; 45(4):511-7. PubMed ID: 27103599
[TBL] [Abstract][Full Text] [Related]
4. Effects of ApoE4 and ApoE2 genotypes on subcortical magnetic susceptibility and microstructure in 27,535 participants from the UK Biobank.
Nir TM; Zhu AH; Gari IB; Dixon D; Islam T; Villalon-Reina JE; Medland SE; Thompson PM; Jahanshad N
Pac Symp Biocomput; 2022; 27():121-132. PubMed ID: 34890142
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's Disease Susceptibility Gene Apolipoprotein E (APOE) and Blood Biomarkers in UK Biobank (N = 395,769).
Ferguson AC; Tank R; Lyall LM; Ward J; Celis-Morales C; Strawbridge R; Ho F; Whelan CD; Gill J; Welsh P; Anderson JJ; Mark PB; Mackay DF; Smith DJ; Pell JP; Cavanagh J; Sattar N; Lyall DM
J Alzheimers Dis; 2020; 76(4):1541-1551. PubMed ID: 32651323
[TBL] [Abstract][Full Text] [Related]
6. Commentary: APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort.
Kasparian K; Graykowski D; Cudaback E
Front Immunol; 2020; 11():1939. PubMed ID: 33042114
[No Abstract] [Full Text] [Related]
7. APOE targeting strategy in Alzheimer's disease: lessons learned from protective variants.
Bu G
Mol Neurodegener; 2022 Aug; 17(1):51. PubMed ID: 35922805
[No Abstract] [Full Text] [Related]
8. APOE in Alzheimer's disease and neurodegeneration.
Butterfield DA; Johnson LA
Neurobiol Dis; 2020 Jun; 139():104847. PubMed ID: 32209402
[No Abstract] [Full Text] [Related]
9. Influence of Western diet and APOE genotype on Alzheimer's disease risk.
Sullivan PM
Neurobiol Dis; 2020 May; 138():104790. PubMed ID: 32032732
[No Abstract] [Full Text] [Related]
10. Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease.
Le Guen Y; Belloy ME; Grenier-Boley B; de Rojas I; Castillo-Morales A; Jansen I; Nicolas A; Bellenguez C; Dalmasso C; Küçükali F; Eger SJ; Rasmussen KL; Thomassen JQ; Deleuze JF; He Z; Napolioni V; Amouyel P; Jessen F; Kehoe PG; van Duijn C; Tsolaki M; Sánchez-Juan P; Sleegers K; Ingelsson M; Rossi G; Hiltunen M; Sims R; van der Flier WM; Ramirez A; Andreassen OA; Frikke-Schmidt R; Williams J; Ruiz A; Lambert JC; Greicius MD; ; Arosio B; Benussi L; Boland A; Borroni B; Caffarra P; Daian D; Daniele A; Debette S; Dufouil C; Düzel E; Galimberti D; Giedraitis V; Grimmer T; Graff C; Grünblatt E; Hanon O; Hausner L; Heilmann-Heimbach S; Holstege H; Hort J; Jürgen D; Kuulasmaa T; van der Lugt A; Masullo C; Mecocci P; Mehrabian S; de Mendonça A; Moebus S; Nacmias B; Nicolas G; Olaso R; Papenberg G; Parnetti L; Pasquier F; Peters O; Pijnenburg YAL; Popp J; Rainero I; Ramakers I; Riedel-Heller S; Scarmeas N; Scheltens P; Scherbaum N; Schneider A; Seripa D; Soininen H; Solfrizzi V; Spalletta G; Squassina A; van Swieten J; Tegos TJ; Tremolizzo L; Verhey F; Vyhnalek M; Wiltfang J; Boada M; García-González P; Puerta R; Real LM; Álvarez V; Bullido MJ; Clarimon J; García-Alberca JM; Mir P; Moreno F; Pastor P; Piñol-Ripoll G; Molina-Porcel L; Pérez-Tur J; Rodríguez-Rodríguez E; Royo JL; Sánchez-Valle R; Dichgans M; Rujescu D
JAMA Neurol; 2022 Jul; 79(7):652-663. PubMed ID: 35639372
[TBL] [Abstract][Full Text] [Related]
11. Rare APOE Missense Variants-Can We Overcome APOE ε4 and Alzheimer Disease Risk?
Rabinovici GD; Dubal DB
JAMA Neurol; 2022 Jul; 79(7):649-651. PubMed ID: 35639398
[No Abstract] [Full Text] [Related]
12. ApoE e4e4 Genotype and Mortality With COVID-19 in UK Biobank.
Kuo CL; Pilling LC; Atkins JL; Masoli JAH; Delgado J; Kuchel GA; Melzer D
J Gerontol A Biol Sci Med Sci; 2020 Sep; 75(9):1801-1803. PubMed ID: 32623451
[No Abstract] [Full Text] [Related]
13. Refining Risk for Alzheimer's Disease Among Heterozygous APOEɛ4 Carriers.
Patel S; Wei J; Shi Z; Rifkin AS; Zheng SL; Gelfman E; Duggan D; Helfand BT; Hulick PJ; Xu J
J Alzheimers Dis; 2023; 94(2):483-489. PubMed ID: 37334598
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E (APOE) genotype-associated disease risks: a phenome-wide, registry-based, case-control study utilising the UK Biobank.
Lumsden AL; Mulugeta A; Zhou A; Hyppönen E
EBioMedicine; 2020 Sep; 59():102954. PubMed ID: 32818802
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E genotype, lifestyle and coronary artery disease: Gene-environment interaction analyses in the UK Biobank population.
Bos MM; de Vries L; Rensen PC; Willems van Dijk K; Blauw GJ; van Heemst D; Noordam R
Atherosclerosis; 2021 Jul; 328():33-37. PubMed ID: 34082327
[TBL] [Abstract][Full Text] [Related]
16. APOE gene-dependent BOLD responses to a breath-hold across the adult lifespan.
Rasmussen PM; Aamand R; Weitzberg E; Christiansen M; Østergaard L; Lund TE
Neuroimage Clin; 2019; 24():101955. PubMed ID: 31408838
[TBL] [Abstract][Full Text] [Related]
17. Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.
Dunk MM; Driscoll I;
J Alzheimers Dis; 2022; 85(4):1519-1528. PubMed ID: 34958023
[TBL] [Abstract][Full Text] [Related]
18. Physical Activity, APOE Genotype, and Cognitive Decline: Exploring Gene-Environment Interactions in the UK Biobank.
Folley S; Zhou A; Llewellyn DJ; Hyppönen E
J Alzheimers Dis; 2019; 71(3):741-750. PubMed ID: 31450492
[TBL] [Abstract][Full Text] [Related]
19. Association between polygenic risk for Alzheimer's disease, brain structure and cognitive abilities in UK Biobank.
Tank R; Ward J; Flegal KE; Smith DJ; Bailey MES; Cavanagh J; Lyall DM
Neuropsychopharmacology; 2022 Jan; 47(2):564-569. PubMed ID: 34621014
[TBL] [Abstract][Full Text] [Related]
20. Factors Influencing Alzheimer's Disease Risk: Whether and How They are Related to the APOE Genotype.
Zhang R; Xu X; Yu H; Xu X; Wang M; Le W
Neurosci Bull; 2022 Jul; 38(7):809-819. PubMed ID: 35149974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
